MSPrecise: Breakthrough nextgen sequencing, 1st in class 80% accurate, cut point is 6.8 accuracy for diagnosing MS goes from 58% to 92% when MSPrecise is used as an addon. Used 330 patients with a P value lower than .001. MSPrecise will be the commercial lead for AMBS DX division
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links